+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

From
From
Microscopic Polyangiitis (MPA)- Epidemiology Forecast to 2032 - Product Thumbnail Image

Microscopic Polyangiitis (MPA)- Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Rheumatoid Arthritis (RA) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Rheumatoid Arthritis (RA) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Sjogren's Syndrome - Epidemiology Forecast to 2032 - Product Thumbnail Image

Sjogren's Syndrome - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Interferon - Biosimilar Insight, 2022 - Product Thumbnail Image

Interferon - Biosimilar Insight, 2022

  • Report
  • January 2022
  • 70 Pages
  • Global
From
Infliximab-Biosimilars Insight, 2022 - Product Thumbnail Image

Infliximab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Adalimumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Adalimumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Pemphigus Vulgaris (PV)-Epidemiology Forecast - 2032 - Product Thumbnail Image

Pemphigus Vulgaris (PV)-Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
From
Tadekinig Alfa - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

Tadekinig Alfa - Emerging Insight and Market Forecast - 2030

  • Report
  • April 2021
  • 35 Pages
  • Global
From
HYQVIA - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

HYQVIA - Emerging Insight and Market Forecast - 2030

  • Report
  • February 2021
  • 30 Pages
  • Global
From
Ilaris - Drug Insight and Market Forecast - 2030 - Product Thumbnail Image

Ilaris - Drug Insight and Market Forecast - 2030

  • Report
  • December 2020
  • 60 Pages
  • Global
From
ANAKINRA - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

ANAKINRA - Emerging Insight and Market Forecast - 2030

  • Report
  • December 2020
  • 60 Pages
  • Global
From
From
From
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more